Santa Cruz Biotechnology

Brm (E-1) | Santa Cruz Biotechnology

mouse monoclonal IgM; Brm Antibody (E-1) is an IgM κ mouse monoclonal Brm antibody (also designated SWI/SNF Related Matrix Associated Actin Dependent Regulator Of Chromatin Subfamily A Member 2 antibody, HBRM antibody, BRM antibody, Probable Global Transcription Activator SNF2L2 antibody, ATP-Dependent Helicase SMARCA2 antibody, BRG1-Associated Factor 190B antibody, Brahma Homolog antibody, SNF2-Alpha antibody, BAF190B antibody, BAF190 antibody, SNF2L2 antibody, SNF2LA antibody, HSNF2a antibody, Sth1p antibody, SNF2 antibody, SWI/SNF-Related Matrix-Associated Actin-Dependent Regulator Of Chromatin A2 antibody, or NF2/SWI2-Like Protein 2 antibody) that detects the Brm protein of mouse, rat and human origin by WB, IP, IF and ELISA. Brm Antibody (E-1) is available as both the non-conjugated anti-Brm antibody form, as well as multiple conjugated forms of anti-Brm antibody, including agarose. The Brahma protein (Brm) is an ATPase subunit of the Drosophila melanogaster Brm complex, which is highly related to the mammalian SWI/SNF chromatin-remodeling complex. Brm is a transcriptional activator of Hox genes and associates with nearly all transcriptionally active chromatin in a pattern that is non-overlapping with that of Polycomb, a repressor of Hox gene transcription. The Brm complex is an essential coactivator for the trithorax group protein Zeste, a DNA-binding activator of homeotic genes. Reduction of Brm function dramatically reduces the association of RNA polymerase II with Drosophila salivary gland chromosomes, suggesting that the chromatin remodeling activity of the Brm complex plays a general role in facilitating transcription by RNA polymerase II. Brm acts as a dominant suppressor of the rough eye phenotype that results from a hypomorphic mutation of Drosophila cyclin E by inhibiting S phase entry by acting downstream of cyclin E protein accumulation. The interaction of the Brm complex with chromatin may be modulated by BAP111, which is highly associated with the Brm complex in Drosophila embryos via an HMG domain. Brm is highly expressed in unfertilized eggs and early embryos.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.